ADHERENCE TO NEBULISED THERAPIES IN PEOPLE WITH CYSTIC FIBROSIS STARTING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR (KAFTRIO)

被引：1
|
作者：
Howell, I. B. [1 ]
Tugwell, A. [1 ]
Bhaskaran, D. [1 ]
Bell, N. J. [1 ]
机构：
[1] Bristol Adult Cyst Fibrosis Ctr, Bristol, Avon, England
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2021-BTSabstracts.65
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S59
引用
收藏
页码：A40 / A40
页数：1
相关论文
共 50 条
  • [41] Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor
    Sanders, Don B.
    Mayer-Hamblett, Nicole
    Rosenfeld, Margaret
    Polinieni, Deepika
    Dasenbrook, Elliott
    Szczesniak, Rhonda
    Cromwell, Elizabeth A.
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (02) : 255 - 262
  • [42] Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
    Donaldson, Scott H.
    Corcoran, Timothy E.
    Pilewski, Joseph M.
    Mogayzel, Peter
    Laube, Beth L.
    Boitet, Evan R.
    Harris, Elex S.
    Ceppe, Agathe
    Edwards, Lloyd J.
    Zeman, Kirby
    Wu, Jihong
    Esther, Charles R.
    Nichols, David P.
    Bennett, William D.
    Rowe, Steven M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 155 - 160
  • [43] Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
    Stapleton, Amanda L.
    Kimple, Adam J.
    Goralski, Jennifer L.
    Nouraie, S. Mehdi
    Branstetter, Barton F.
    Shaffer, Amber
    Pilewski, Joseph M.
    Senior, Brent A.
    Lee, Stella E.
    Zemke, Anna C.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (05) : 792 - 799
  • [44] Exercise tolerance in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor
    Hrvoic, Lovro
    Bambir, Ivan
    Omerza, Lana
    Todoric, Ivana
    Markelic, Ivona
    Dugac, Andrea Vukic
    Tjesic-Drinkovic, Duska
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [45] Peripheral lung effect of elexacaftor/tezacaftor/ivacaftor in adult cystic fibrosis
    Stylemans, Dimitri
    Darquenne, Chantal
    Schuermans, Daniel
    Verbanck, Sylvia
    Vanderhelst, Eef
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : 160 - 163
  • [46] Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis
    Morgan, Sarah J.
    Nichols, David P.
    Ni, Windy
    Hong, Gina
    Salipante, Stephen J.
    Solomon, George M.
    Rowe, Steven M.
    Clancy, John P.
    Cramer, Robert A.
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (09) : 1155 - 1158
  • [47] The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
    Scully, Kevin J.
    Marchetti, Peter
    Sawicki, Gregory S.
    Uluer, Ahmet
    Cernadas, Manuela
    Cagnina, Rebecca E.
    Kennedy, John C.
    Putman, Melissa S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 258 - 263
  • [48] Elexacaftor/Tezacaftor/Ivacaftor as a Bridge to Lung Retransplant in a Recipient With Cystic Fibrosis
    FitzMaurice, Thomas Simon
    Nazareth, Dilip
    Iyer, Kapil
    Walshaw, Martin
    Al-Aloul, Mohamed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (04) : 433 - 435
  • [49] Development of elexacaftor - tezacaftor - ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis
    Middleton, Peter G.
    Taylor-Cousar, Jennifer L.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (06) : 723 - 735
  • [50] EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS
    Lee, Tim
    Sawicki, Gregory S.
    Altenburg, Josje
    Millar, Stefanie J.
    Geiger, Jessica Morlando
    Jennings, Mark T.
    Lou, Yiyue
    McGarry, Lisa J.
    Van Brunt, Kate
    Linnemann, Rachel W.
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (03) : 402 - 406
12345